Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2025-03-12
2025-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be randomly divided into three groups. The first group will receive radial shock waves (rESWT), the second group will receive focal shock waves (fESWT), and the third group, which will act as a control, will receive a placebo treatment with very low energy parameters according to the literature.
Subjects will receive three sessions, one session per week.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Shockwave Therapy Versus Focused Shockwave Therapy in Patients With Lateral Epicondylitis
NCT05853029
Effectiveness of Radial Extracorporeal Shock Wave Therapy and Supervised Exercises in Lateral Epicondylitis
NCT03834090
The Effects of Radial and Focused Extracorporeal Shock Wave Therapies on Lateral Epicondylitis
NCT04838002
Effectiveness of Extracorporeal Shockwave Therapy and Nutraceutical Supplementation in the Treatment of Epicondylitis: a Clinical Trial
NCT06442618
Shockwave Therapy Plus Exercise for Lateral Epicondylitis
NCT07282431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Radial Shock Wave Treatment
Patients assigned to this group will receive three sessions. During each session, 2000 pulses will be administered using a radial shock wave generator, with a pressure of 2.5 bars and a frequency of 8 Hz.
Radial shock waves treatment
Subjects in this group will receive radial shock waves
Focal Shock Wave Treatment
Patients assigned to this group will receive three sessions. During each session, 2000 pulses will be delivered by a focal shock wave generator, with an energy flux density of 0.2 mJ/mm² and a frequency of 4 Hz.
Focal Shock Waves treatment
Subjects in this group will receive focal shock waves
Placebo Shock Waves
Subjects in this group will receive a placebo treatment with very low energy settings, designed to simulate therapy without offering real therapeutic effects. This group will receive 20 pulses per session, with an energy flux density of 0.08 mJ/mm².
shock waves placebo treatment
Subjects in this group will receive a shock waves placebo treatment with very low energy settings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radial shock waves treatment
Subjects in this group will receive radial shock waves
Focal Shock Waves treatment
Subjects in this group will receive focal shock waves
shock waves placebo treatment
Subjects in this group will receive a shock waves placebo treatment with very low energy settings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pain when performing resisted grip
* Positive Cozen test
* Positive Maudsley test
Exclusion Criteria
* Systemic diseases (Fibromyalgia, Diabetes, Arthritis)
* Local infection or Cancer
* Recent treatments (Physiotherapy, Corticosteroids)-
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alcala
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Daniel Pecos Martín
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Investigación Fisioterapia y Dolor
Alcalá de Henares, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEIM/2024/4/101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.